Showing results (21-30 of 111) with videos related to

Sort By:
Pageof 12
ILIVER|July 10, 2025
Practice revolution in local interventional therapy for liver metastasesHongjun Yuan, Hongli Yu, Ying Guan, et al.
Synthetic and Systems Biotechnology|June 16, 2023
Explore the dominant factor in prime editing via a view of DNA processingZhimeng Xu, Dacheng Ma, Houzhen Su, et al.
Medical Review (2021)|March 5, 2026
Research progress on immune tolerance mechanisms in liver metastatic tumors and the "Liver-metastasis-oriented shared-mechanism therapeutic strategy" approachQing Zhang, Wenjing Wang, Hongli Yu, et al.
Therapeutic Advances in Medical Oncology|January 16, 2025
Prognostic impact of primary versus secondary resistance to sorafenib in patients with HCCJin Lei, Hongyuan Dai, Ya Zhang, et al.
Nature Communications|October 24, 2019
Oncolytic adenovirus programmed by synthetic gene circuit for cancer immunotherapyHuiya Huang, Yiqi Liu, Weixi Liao, et al.
Frontiers in Microbiology|April 4, 2022
Intestinal <i>Candida albicans</i> Promotes Hepatocarcinogenesis by Up-Regulating NLRP6Zherui Liu, Yinyin Li, Chen Li, et al.
Cellular Signalling|September 10, 2013
LINE-1 ORF-1p functions as a novel HGF/ETS-1 signaling pathway co-activator and promotes the growth of MDA-MB-231 cellQian Yang, Fan Feng, Fan Zhang, et al.
Frontiers in Oncology|February 8, 2021
Establishment of Criteria for Molecular Differential Diagnosis of MPLC and IPMXiaohui Wang, Yuan Gong, Jianfei Yao, et al.
Liver Cancer|August 8, 2024
Chinese Multidisciplinary Expert Consensus on Immune Checkpoint Inhibitor-Based Combination Therapy for Hepatocellular Carcinoma (2023 Edition)Xiufeng Liu, Yinying Lu, Weiping Zhou, et al.
Journal of Cellular Physiology|February 14, 2020
KIF18B promotes hepatocellular carcinoma progression through activating Wnt/β-catenin-signaling pathwayBin Yang, Shengzhi Wang, Hui Xie, et al.
Pageof 12